| P2093 | author name string | Cleary J | |
| | Kim EM | |
| | O'Hare E | |
| | Richardson RL | |
| | Shephard RA | |
| | Gardiner T | |
| P2860 | cites work | Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein | Q22251280 |
| | Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease | Q28241772 |
| | The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease | Q28610089 |
| | Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 |
| | Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline | Q33895797 |
| | Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production | Q34280406 |
| | Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease | Q34309107 |
| | Regional differences in reactive gliosis induced by substrate-bound beta-amyloid | Q34315949 |
| | Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody | Q34678250 |
| | The participation of interleukin-6 in the pathogenesis of alzheimer's disease | Q35155272 |
| | Glial cytokines in Alzheimer's disease: Review and pathogenic implications | Q37520360 |
| | An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P | Q37581011 |
| | Effects of injected Alzheimer beta-amyloid cores in rat brain. | Q37596908 |
| | Neuroimmune mechanisms in Alzheimer disease pathogenesis | Q40647382 |
| | Alzheimer's disease: a central role for amyloid | Q40701623 |
| | Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease | Q40870408 |
| | Microglia in degenerative neurological disease. | Q40870414 |
| | A case-control study of Alzheimer's disease in Australia | Q41198222 |
| | Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography | Q41435233 |
| | A case-control study of dementia of the Alzheimer type | Q41500631 |
| | Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. | Q41712816 |
| | Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects | Q42672221 |
| | Astrocytes and the plaques of Alzheimer's disease | Q43518624 |
| | Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures | Q44494256 |
| | Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group | Q44498649 |
| | Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state | Q44689258 |
| | Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease | Q44940085 |
| | β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease | Q46052685 |
| | Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease | Q46374518 |
| | Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity | Q46692414 |
| | Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42). | Q48285810 |
| | Effect of beta amyloid peptides on neurons in hippocampal slice cultures | Q48435583 |
| | In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment | Q48435587 |
| | beta-Amyloid peptide in vitro toxicity: lot-to-lot variability | Q48443223 |
| | Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein | Q48634030 |
| | A beta deposition inhibitor screen using synthetic amyloid | Q48790396 |
| | Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats | Q48865867 |
| | Alternating lever cyclic-ratio schedule analysis of the effects of atropine sulfate | Q49121459 |
| | Beta-amyloid(1-40) effects on behavior and memory. | Q52052760 |
| | Cholecystokinin, diet palatability, and feeding regulation in rats. | Q52263958 |
| | Operant regulation of feeding: a static analysis. | Q52280318 |
| | Decreased feeding associated with acute hypoxia in rats. | Q52286453 |
| | Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. | Q52509135 |
| | Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. | Q52884779 |
| | Anti-inflammatory drugs and Alzheimer disease. | Q53183421 |
| | Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. | Q53189340 |
| | Rheumatoid arthritis and senile dementia of the Alzheimer's type. | Q53190347 |
| | Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. | Q53199651 |
| | beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. | Q53317817 |
| | Clinical trial of indomethacin in Alzheimer's disease. | Q53318286 |
| | Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study | Q57782164 |
| | The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases | Q71674774 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-10 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Abeta(1-42) injections in the rat. | |
| P478 | volume | 954 | |